BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8386373)

  • 41. Bacterial transposases and retroviral integrases.
    Polard P; Chandler M
    Mol Microbiol; 1995 Jan; 15(1):13-23. PubMed ID: 7752887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeting of retroviral integrase by fusion to a heterologous DNA binding domain: in vitro activities and incorporation of a fusion protein into viral particles.
    Katz RA; Merkel G; Skalka AM
    Virology; 1996 Mar; 217(1):178-90. PubMed ID: 8599202
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of the minimal DNA-binding domain of the HIV integrase protein.
    Lutzke RA; Vink C; Plasterk RH
    Nucleic Acids Res; 1994 Oct; 22(20):4125-31. PubMed ID: 7937137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.
    Dyda F; Hickman AB; Jenkins TM; Engelman A; Craigie R; Davies DR
    Science; 1994 Dec; 266(5193):1981-6. PubMed ID: 7801124
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.
    Cannon PM; Wilson W; Byles E; Kingsman SM; Kingsman AJ
    J Virol; 1994 Aug; 68(8):4768-75. PubMed ID: 8035478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo.
    Faust EA; Acel A; Udashkin B; Wainberg MA
    Biochem Mol Biol Int; 1995 Jul; 36(4):745-58. PubMed ID: 8528137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization, and enhances catalytic activity.
    Zheng R; Jenkins TM; Craigie R
    Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13659-64. PubMed ID: 8942990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Solution structure of the DNA binding domain of HIV-1 integrase.
    Lodi PJ; Ernst JA; Kuszewski J; Hickman AB; Engelman A; Craigie R; Clore GM; Gronenborn AM
    Biochemistry; 1995 Aug; 34(31):9826-33. PubMed ID: 7632683
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The DNA-binding domain of HIV-1 integrase has an SH3-like fold.
    Eijkelenboom AP; Lutzke RA; Boelens R; Plasterk RH; Kaptein R; Hård K
    Nat Struct Biol; 1995 Sep; 2(9):807-10. PubMed ID: 7552753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2.
    van Gent DC; Elgersma Y; Bolk MW; Vink C; Plasterk RH
    Nucleic Acids Res; 1991 Jul; 19(14):3821-7. PubMed ID: 1861975
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.
    Mazumder A; Wang S; Neamati N; Nicklaus M; Sunder S; Chen J; Milne GW; Rice WG; Burke TR; Pommier Y
    J Med Chem; 1996 Jun; 39(13):2472-81. PubMed ID: 8691444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nucleotide binding by the HIV-1 integrase protein in vitro.
    Lipford JR; Worland ST; Farnet CM
    J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1215-23. PubMed ID: 7965631
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conserved amino acid motifs from the novel Piv/MooV family of transposases and site-specific recombinases are required for catalysis of DNA inversion by Piv.
    Tobiason DM; Buchner JM; Thiel WH; Gernert KM; Karls AC
    Mol Microbiol; 2001 Feb; 39(3):641-51. PubMed ID: 11169105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.
    LaFemina RL; Schneider CL; Robbins HL; Callahan PL; LeGrow K; Roth E; Schleif WA; Emini EA
    J Virol; 1992 Dec; 66(12):7414-9. PubMed ID: 1433523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Conserved sequences in the carboxyl terminus of integrase that are essential for human immunodeficiency virus type 1 replication.
    Cannon PM; Byles ED; Kingsman SM; Kingsman AJ
    J Virol; 1996 Jan; 70(1):651-7. PubMed ID: 8523588
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ubiquitination of non-lysine residues in the retroviral integrase.
    Wang Z; Hou X; Wang Y; Xu A; Cao W; Liao M; Zhang R; Tang J
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):57-62. PubMed ID: 29054407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Binding of different divalent cations to the active site of avian sarcoma virus integrase and their effects on enzymatic activity.
    Bujacz G; Alexandratos J; Wlodawer A; Merkel G; Andrake M; Katz RA; Skalka AM
    J Biol Chem; 1997 Jul; 272(29):18161-8. PubMed ID: 9218451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutational analysis of the integrase protein of human immunodeficiency virus type 2.
    van Gent DC; Groeneger AA; Plasterk RH
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9598-602. PubMed ID: 1409671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.
    Kalpana GV; Marmon S; Wang W; Crabtree GR; Goff SP
    Science; 1994 Dec; 266(5193):2002-6. PubMed ID: 7801128
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
    Mazumder A; Cooney D; Agbaria R; Gupta M; Pommier Y
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5771-5. PubMed ID: 8016063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.